Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 714

1.

Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats.

Vickers SP, Webster LJ, Wyatt A, Dourish CT, Kennett GA.

Psychopharmacology (Berl). 2003 Apr;167(1):103-11. Epub 2003 Mar 11.

PMID:
12632249
[PubMed - indexed for MEDLINE]
2.

Oral administration of the 5-HT2Creceptor agonist, mCPP, reduces body weight gain in rats over 28 days as a result of maintained hypophagia.

Vickers SP, Easton N, Webster LJ, Wyatt A, Bickerdike MJ, Dourish CT, Kennett GA.

Psychopharmacology (Berl). 2003 May;167(3):274-80. Epub 2003 Apr 11.

PMID:
12690422
[PubMed - indexed for MEDLINE]
3.

Appetite suppression and weight loss after the cannabinoid antagonist SR 141716.

Colombo G, Agabio R, Diaz G, Lobina C, Reali R, Gessa GL.

Life Sci. 1998;63(8):PL113-7.

PMID:
9718088
[PubMed - indexed for MEDLINE]
4.

Chronic intracerebroventricular administration of recombinant CART(42-89) peptide inhibits and causes weight loss in lean and obese Zucker (fa/fa) rats.

Larsen PJ, Vrang N, Petersen PC, Kristensen P.

Obes Res. 2000 Nov;8(8):590-6.

PMID:
11156435
[PubMed - indexed for MEDLINE]
5.

The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells.

Bensaid M, Gary-Bobo M, Esclangon A, Maffrand JP, Le Fur G, Oury-Donat F, Soubrié P.

Mol Pharmacol. 2003 Apr;63(4):908-14.

PMID:
12644592
[PubMed - indexed for MEDLINE]
Free Article
6.

Effect of phenylpiperidine opioid antagonists on food consumption and weight gain of the obese Zucker rat.

Shaw WN, Mitch CH, Leander JD, Zimmerman DM.

J Pharmacol Exp Ther. 1990 Apr;253(1):85-9.

PMID:
2329525
[PubMed - indexed for MEDLINE]
7.

The cannabinoid CB1 receptor inverse agonist, rimonabant, modifies body weight and adiponectin function in diet-induced obese rats as a consequence of reduced food intake.

Thornton-Jones ZD, Kennett GA, Benwell KR, Revell DF, Misra A, Sellwood DM, Vickers SP, Clifton PG.

Pharmacol Biochem Behav. 2006 Jun;84(2):353-9. Epub 2006 Jun 30.

PMID:
16814374
[PubMed - indexed for MEDLINE]
8.

LY226936 administered orally and centrally to obese Zucker rats suppresses food intake and body weight gain.

Shaw WN, Clemens JA, Panetta JA.

Obes Res. 1994 Sep;2(5):458-68.

PMID:
16353597
[PubMed - indexed for MEDLINE]
9.

Effects of simmondsin on food intake, growth, and metabolic variables in lean (+/?) and obese (fa/fa) Zucker rats.

Flo G, Vermaut S, Darras VM, Van Boven M, Decuypere E, Kühn ER, Daenens P, Cokelaere M.

Br J Nutr. 1999 Feb;81(2):159-67.

PMID:
10450335
[PubMed - indexed for MEDLINE]
10.

Effects of the cannabinoid receptor antagonist SR 141716, alone and in combination with dexfenfluramine or naloxone, on food intake in rats.

Rowland NE, Mukherjee M, Robertson K.

Psychopharmacology (Berl). 2001 Dec;159(1):111-6. Epub 2001 Oct 2.

PMID:
11797078
[PubMed - indexed for MEDLINE]
11.
12.

Acute anorectic response to cannabinoid CB1 receptor antagonist/inverse agonist AM 251 in rats: indirect behavioural mediation.

Tallett AJ, Blundell JE, Rodgers JR.

Behav Pharmacol. 2007 Nov;18(7):591-600.

PMID:
17912043
[PubMed - indexed for MEDLINE]
13.

Attenuation of hyperinsulinemia by NN414, a SUR1/Kir6.2 selective K-adenosine triphosphate channel opener, improves glucose tolerance and lipid profile in obese Zucker rats.

Alemzadeh R, Fledelius C, Bodvarsdottir T, Sturis J.

Metabolism. 2004 Apr;53(4):441-7.

PMID:
15045689
[PubMed - indexed for MEDLINE]
14.

Effects of rimonabant on behavior maintained by progressive ratio schedules of sucrose reinforcement in obese Zucker (fa/fa) rats.

Rasmussen EB, Huskinson SL.

Behav Pharmacol. 2008 Oct;19(7):735-42. doi: 10.1097/FBP.0b013e3283123cc2.

PMID:
18797250
[PubMed - indexed for MEDLINE]
15.

Novel effects of the cannabinoid inverse agonist AM 251 on parameters related to metabolic syndrome in obese Zucker rats.

Merroun I, Sánchez-González C, Martínez R, López-Chaves C, Porres JM, Aranda P, Llopis J, Galisteo M, Zarzuelo A, Errami M, López-Jurado M.

Metabolism. 2013 Nov;62(11):1641-50. doi: 10.1016/j.metabol.2013.06.011. Epub 2013 Aug 6.

PMID:
23932644
[PubMed - indexed for MEDLINE]
16.

Central melanocortin system modulates energy intake and expenditure of obese and lean Zucker rats.

Hwa JJ, Ghibaudi L, Gao J, Parker EM.

Am J Physiol Regul Integr Comp Physiol. 2001 Aug;281(2):R444-51.

PMID:
11448846
[PubMed - indexed for MEDLINE]
Free Article
17.
18.

Age-dependent effects of the cannabinoid CB1 antagonist SR141716A on food intake, body weight change, and pruritus in rats.

Ward SJ, Lefever TW, Rawls SM, Whiteside GT, Walker EA.

Psychopharmacology (Berl). 2009 Sep;206(1):155-65. doi: 10.1007/s00213-009-1592-6. Epub 2009 Jul 3.

PMID:
19575185
[PubMed - indexed for MEDLINE]
19.

Time-dependent effects of progressive gamma-linolenate feeding on hyperphagia, weight gain, and erythrocyte fatty acid composition during growth of Zucker obese rats.

Thurmond DC, Tang AB, Nakamura MT, Stern JS, Phinney SD.

Obes Res. 1993 Mar;1(2):118-25.

PMID:
16353349
[PubMed - indexed for MEDLINE]
20.

Diazoxide enhances basal metabolic rate and fat oxidation in obese Zucker rats.

Alemzadeh R, Karlstad MD, Tushaus K, Buchholz M.

Metabolism. 2008 Nov;57(11):1597-607. doi: 10.1016/j.metabol.2008.06.017.

PMID:
18940400
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk